SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 41.10 |
| Enterprise Value ($M) | 62.74 |
| Book Value ($M) | -11.51 |
| Book Value / Share | -0.51 |
| Price / Book | -3.57 |
| NCAV ($M) | -12.93 |
| NCAV / Share | -0.47 |
| Price / NCAV | -3.18 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.23 |
| Return on Assets (ROA) | -0.77 |
| Return on Equity (ROE) | -8.90 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.78 |
| Current Ratio | 0.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 14.50 |
| Assets | 15.92 |
| Liabilities | 27.43 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 6.03 | 20.27 | |
| 13G/A | Point72 Asset Management, L.P. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 491,748 | 1,425,200 | 34.50 | |
| 240,640 | 713,683 | 33.72 | |
| 595,099 | 1,573,497 | 37.82 | |
| 284,771 | 1,012,322 | 28.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| INMB – INmune Bio, Inc. | INTS – Intensity Therapeutics, Inc. |
| IRD – Opus Genetics, Inc. | JAGX – Jaguar Health, Inc. |
| JSPR – Jasper Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io